Reuters logo
8 months ago
BRIEF-Proteostasis Therapeutics - Co received notice from Biogen of termination of collaborative research, development, commercialization, license agreement
December 9, 2016 / 10:10 PM / 8 months ago

BRIEF-Proteostasis Therapeutics - Co received notice from Biogen of termination of collaborative research, development, commercialization, license agreement

1 Min Read

Dec 9 (Reuters) - Proteostasis Therapeutics Inc

* Proteostasis Therapeutics - on Dec 5, co received notice from biogen of termination of collaborative research, development, commercialization, license agreement

* Biogen's termination effective as of December 6, 2016

* Proteostasis Therapeutics - termination of collaboration to develop, commercialize products to attack toxic proteins implicated in development of Alzheimer's, Parkinson's diseases Source text - bit.ly/2hvaQv6 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below